RPS, The Next Generation CRO, provides comprehensive global Phase II-IV clinical development solutions to the Pharmaceutical, Biotechnology, Medical Device and Diagnostic industries.  By combining an experienced clinical research operations infrastructure with the industry's largest resourcing engines, RPS is uniquely positioned to offer our Customers a broad spectrum of outsourcing solutions.  These solutions range from globally Embedded functional and cross-functional programs to enhanced global full-service solutions, and are powered by highly experienced project teams providing innovative, seamless, cost-effective and high quality services.  With more than 4,000 employees, RPS operates in 64 countries across the globe.

CTMS, Inc., a privately held CRO, provides the complete scope of clinical trial management, data management, regulatory and feasibility services for the pharmaceutical, bio-tech and medical device industries.   Our full-service and task-based capabilities extend to clients throughout North America and Europe.  Our metrics reveal our distinctives, a few of which are summarized below:
96% of all studies have been completed without a CTMS-initiated Change in Scope
Our satisfied client repeat and/or referred business averages 97%
Company-wide cumulative retention rate averages 94% for the last 5 years. 
Extraordinarily low database error rate of .0007536
Since 1989, CTMS has provided quality-centered services to Top 10 pharmaceutical, biotechnology, mid-sized and specialty pharma companies.  Discover why CTMS is A Refreshingly Different CRO.  

We are a therapeutically focused contract research organization with a high performance reputation for conducting global clinical development programs of the highest integrity. Pharmaceutical and biotechnology companies look to INC Research for a complete range of customized Phase I - Phase IV programs in therapeutic areas of specialty, and in innovative pediatric and women’s health trials. Our Trusted Process® methodology and therapeutic foresight leads our customers to more confident, better-informed drug and device development decisions.

PharmaNet Development Group, a recognized leader of global drug development services to the pharmaceutical, biotechnology, generic drug, and medical device industries, provides comprehensive capabilities in Phase I-IV clinical development, bioanalytical and bioequivalence services, regulatory, staffing, and therapeutic solutions. For the applied knowledge and intelligent solutions needed to accelerate drug development programs of all sizes around the world, PharmaNet works for you.

PPD is a leading global contract research organization providing discovery, development and lifecycle management services. Our clients and partners include pharmaceutical, biotechnology, medical device, academic and government organizations. Through strong strategic alliances and close partnership with our clients, we apply innovative technologies, therapeutic expertise and quality services to help maximize returns on R&D investments and accelerate delivery of safe, effective therapeutics.

Quintiles is the only fully integrated biopharmaceutical services provider offering clinical, commercial consulting and capital solutions worldwide. We help customers manage change, navigate risk and seize opportunities in the new health landscape. Quintiles' more than 24,000 talented, engaged employees in nearly 60 countries deliver on promises to customers every day, working with an unwavering commitment to patients, safety and ethics. As a pioneer in biopharmaceutical services, Quintiles has helped develop or commercialize all of the top 50 best-selling drugs. Quintiles is consistently cited as one of the most favored contract research organization (CRO) in independent surveys of the biopharma industry.

To compete in today’s market, a CRO has to invest in infrastructure and technologies. But Paragon’s leaders also know that success is linked to the people who form the project team. Our focus on people has resulted in 14% annual average turnover and project team stability that conserves Sponsor resources.

Established in 1982, Chiltern is a leading global clinical CRO with extensive experience in the management of Phase I-IV clinical trials across a broad range of therapeutic areas, functional service provision and contract staffing solutions. Chiltern has conducted trials in more than 40 countries, employs 1,400 people globally and offers services in Early Phase, Global Clinical Development, Late Phase, Biometrics, Medical and Regulatory Affairs and Resourcing Solutions. Chiltern prides itself as a development partner that offers flexibility, responsiveness and quality delivery. Further information is available at www.chiltern.com.

Cmed is a full service CRO combining world-class 21st Century technology with exceptional industry experience that offers a unique approach to clinical research and data capture/management that delivers real advantages to its clients. Cmed has engineered and patented a single database system to handle all aspects of the acquisition, management, review and reporting of clinical data program level. From its offices in the US and Europe, Cmed has provided its clients with high quality services and products at competitive prices.

With over 20 years experience, Eurofins Global Central Laboratory serves the pharmaceutical industry, providing unsurpassed quality in laboratory testing, while integrating specialized laboratory services into one project.  Eurofins Global Central Laboratory owns laboratories in Washington DC, Breda, Singapore, Shanghai, and Bangalore (May 2011).  Discover.  Experience.

Formed in 2001 as the for-profit extension of the Ischemia Research and Education Foundation (IREF) – an organization with 20 years of experience in cardiovascular clinical studies – Gentiae is a global leader in comprehensive cardiac safety assessment. Gentiae delivers centralized ECG core lab and imaging services to clients whose clinical trials demand the highest levels of experience and quality clinical interpretation in the analysis of their drug's cardiac safety and functional risk. Leveraging its industry-leading reproducibility and clinical experience, Gentiae is able to deliver tangible value to clients through efficient, cost effective cardiac safety and functional studies in all phases of development.

Kendle is a leading global clinical research organization providing the full range of early- to late-stage clinical development services for the world's biopharmaceutical industry. Our focus is on innovative solutions that reduce cycle times for our customers and accelerate the delivery of life-enhancing products to market for the benefit of patients worldwide. As one of the fastest-growing global providers of Phase I-IV services, we offer experience spanning more than 100 countries, along with industry-leading patient access and retention capabilities and broad therapeutic expertise, to meet our customers' clinical development challenges. www.kendle.com

PRA is transforming clinical trials through our people, innovation and transparency.  PRA provides personalized service customized to the unique requirements of each study. We serve all phases of pharmaceutical and biotech drug development by combining therapeutic and operational expertise with local knowledge; ensuring that sponsors achieve their long-term goals.
 
Serving sponsors for 30+ years, we have amassed a level of expertise that has enabled us to work on a variety of compounds, ranging from niche treatments and therapies to blockbuster drugs.  Our forward-thinking approach to transforming the clinical trial landscape continues to make a difference to healthcare patients around the world.

Reliance Clinical Research Services (RCRS) is a full-service CRO headquartered in Newtown, PA, with core facilities in Mumbai and Bangalore, India. With an organization of over 275 professionals, our services cover the areas of Pre-Clinical, Phase I (including bioequivalence studies), Phases II, III, and IV, Biometrics, Regulatory Affairs, Pharmacovigilence, and Bioanalytical, Diagnostic and Molecular Lab capabilities. The majority of our current clients are US or EU based; we have also successfully completed projects for companies in India, Israel and Japan. For further information, please refer to our website, www.relclin.com.

Tata Consultancy Services (TCS) is an IT services, business solutions and outsourcing organization that delivers real results to global businesses, ensuring a level of certainty no other firm can match. TCS is a preferred partner for six of the top ten global pharmaceutical companies.  TCS provides business process services such as Clinical Data Management, Biostatistics, Medical Writing, Regulatory Reporting and Pharmacovigilance apart from technology services and tools for Clinical trials.